DMT vs LSD: is DMT like acid, and how do the two really differ?

THE SHORT VERSION · SWIPE

▶ Watch it as a 20-second video

‹›

People who search “DMT vs acid” usually want to know two things: is DMT a kind of LSD, and how are the two different? The short answer to the first is no. This page goes deeper on that one pair. For psilocybin alongside both, see our three-way guide to psilocybin, LSD and DMT.

DMT vs acid: how do they compare at a glance?

The table sums up what studies have measured. Each row is explained, with sources, in the sections below. The DMT timing comes from lab studies in which DMT was injected into a vein, a study design rather than a description of everyday use.

Is DMT acid?

No. “Acid” is slang for LSD (lysergic acid diethylamide). PubChem, the US government chemistry database, classes LSD as an ergoline alkaloid, made by joining lysergic acid with diethylamine (PubChem, LSD). It classes DMT (N,N-dimethyltryptamine) as a tryptamine with two methyl groups on its side chain (PubChem, DMT). They are separate molecules with separate entries in Canadian law. Evidence: established.

The mix-up is understandable. Both are classic psychedelics, and a pharmacology review groups LSD and the tryptamines together as indoleamines, drugs built on the same ring-shaped indole core (Halberstadt and Geyer, 2011). A chemistry review notes that DMT’s structure is embedded within LSD’s (Cameron and Olson, 2018). Related is not the same. For other names DMT goes by, see DMT street names. Evidence: established.

What is the difference between DMT and LSD chemically?

DMT is small and simple. A 2018 review calls it the archetype for all indole-containing serotonergic psychedelics, and notes that, unlike LSD, it is produced by a wide variety of plant and animal species. It is one of the few psychedelics made by mammals, and its role in the body “remains a mystery” (Cameron and Olson, 2018). For the molecule itself, see DMT’s chemical structure explained. Evidence: established.

LSD has a different origin. The Swiss chemist Albert Hofmann first made it at Sandoz in Basel in 1938, as part of research on ergot alkaloids, compounds from the ergot fungus (Omidian and Omidian, 2025). Its four-ring ergoline frame is what sets it apart from the tryptamines (PubChem, LSD). Evidence: established.

When were DMT and LSD discovered?

The two stories cross. Szára’s obituary says he made DMT himself after Sandoz declined to send him LSD, and that he was the first to study DMT’s psychotropic effects (Wirz-Justice, 2021). A 2018 review dates the first synthesis to 1931 and the first human reports to 1956 (Barker, 2018). LSD’s 1943 discovery and the end of US clinical research around 1970 come from a review of LSD (Nichols, 2018). More in our history of DMT and Stephen Szára articles. Evidence: established.

Do DMT and LSD work the same way in the brain?

Partly. Both act at the serotonin 5-HT2A receptor, a protein on brain cells that serotonin normally switches on. A review says DMT’s subjective effects “appear to be primarily acting via 5-HT2A receptors”, while it also touches other receptors (Barker, 2018). For LSD, the 5-HT2A role is backed by human blocking studies, summarised, with the full receptor comparison, in our three-way guide. Evidence: established for LSD; for DMT, established in animal and lab work, preliminary in people.

The differences show up in lab tests of receptor binding (how tightly a drug attaches). DMT bound the 5-HT2A receptor less tightly than LSD; LSD, but not DMT, also interacted with adrenergic and dopamine receptors; and DMT, but not LSD, interacted with the serotonin transporter, the pump that clears serotonin away (Rickli et al., 2016). Tighter binding is not the same as a stronger experience. Evidence: established as lab findings, preliminary for what they mean in people.

For this pair, the key lab finding is about time. LSD lets go of the 5-HT2A receptor “exceptionally slow”, and simulations suggest a loop of the receptor forms a “lid” over it (Wacker et al., 2017). DMT, by contrast, is cleared rapidly after injection (Barker, 2018). Those two facts are the leading explanations for why one lasts minutes and the other most of a day, but neither has been shown to explain it in people. Evidence: unresolved. See also DMT and the 5-HT2A receptor.

How long do DMT and LSD last in studies?

This is the biggest measured difference. In a double-blind study of 11 experienced users given DMT into a vein, peak blood levels and effects came within 2 minutes and were negligible at 30 minutes (Strassman and Qualls, 1994). In a later study of 13 volunteers, rated intensity peaked 2 to 3 minutes after injection and stayed above placebo for 17 minutes (Timmermann et al., 2019). Evidence: established for injected DMT in lab conditions.

LSD runs for most of a day. In a double-blind crossover trial of 28 healthy volunteers, LSD effects lasted about 9.3 to 11 hours on average, depending on the amount given (dose not reproduced here), with individual times from about 5 to 20 hours (Holze et al., 2022). An earlier trial of 16 healthy people reported altered consciousness lasting 12 hours (Schmid et al., 2015). Evidence: established for healthy volunteers. For DMT’s timing in more detail, see how long does DMT last.

These are averages from screened volunteers under supervision. They are not a prediction for any one person, and they are not a guide to use.

DMT vs LSD effects: what do people report?

Volunteers in a 1990s DMT study were interviewed after each session. They described a “rush”, a rapidly moving, brightly coloured visual display, and a sense of loss of control leading to a dissociated state, in which euphoria and anxiety alternated or coexisted. The effects replaced their ongoing experience and were described as more vivid than dreams or waking awareness (Strassman et al., 1994). These are reports from 12 experienced volunteers. Evidence: preliminary.

A larger but self-selected source is a study of 3,778 DMT accounts posted to a Reddit forum from 2009 to 2018, all describing inhaled use. Fractals, shapes and patterns appeared in 32.6%, and encounters with “entities” in 45.5%. The median reported experience lasted 10 minutes (Lawrence et al., 2022). Online posts are unverified and not representative. See what does DMT feel like and DMT entity encounters research. Evidence: preliminary.

For LSD, a placebo-controlled trial of 16 healthy people recorded visual hallucinations, audiovisual synaesthesia (sounds experienced as visuals) and derealisation and depersonalisation, feelings that the world or self seem unreal, which the authors describe as positively experienced (Schmid et al., 2015). Ratings of well-being, closeness and trust also rose during the session. These are acute ratings, not lasting effects. Evidence: preliminary.

So is DMT like acid? The reports overlap in their visual changes, but differ in shape: a fast, overwhelming few minutes, sometimes with reported “entities”, against a long, slowly unfolding day. No published study has yet put both side by side in the same people with the same measures. Evidence: unresolved.

Has anyone compared DMT and LSD directly?

Not yet in published form, as far as we could find. University Hospital Basel registered a randomised, placebo-controlled, double-blind crossover study comparing LSD, psilocybin and DMT in about 24 healthy participants. Its stated aim is to test whether equivalent, moderately high doses produce similar peak effects once duration is evened out: DMT is given as an infusion meant to mimic the time course of the other two, and ketanserin, a drug that blocks 5-HT2A, is used to standardise how long the effects last (ClinicalTrials.gov, NCT06899334). Evidence: established for the registration.

The record lists the study as recruiting, last verified in March 2025, with completion estimated for August 2026 (ClinicalTrials.gov, NCT06899334). A Europe PMC search on 21 October 2026 found no published results. When they appear, they will be the first direct test of this pair. The closest published work is a head-to-head trial of LSD and psilocybin, which found their effects did not differ beyond duration (Holze et al., 2022). Evidence: unresolved for DMT vs LSD.

What are the risks of DMT and LSD?

Both raise heart and body measures. Injected DMT raised blood pressure, heart rate, pupil size and body temperature, more so at higher amounts (Strassman and Qualls, 1994). LSD raised blood pressure, heart rate, body temperature and pupil size in healthy volunteers; adverse effects resolved within 72 hours and none were severe in that controlled setting (Schmid et al., 2015). People with heart conditions are usually screened out, so these studies say little about them. Evidence: established for healthy volunteers.

The mind carries risk too. In the DMT interviews, euphoria often came with anxiety (Strassman et al., 1994). In the LSD and psilocybin trial, after-effects included headaches (Holze et al., 2022). A 2025 review of LSD research lists cardiovascular risks, emotional vulnerability and hallucinogen persisting perception disorder (HPPD), lasting visual changes, among its safety considerations (Omidian and Omidian, 2025). See HPPD explained. Evidence: preliminary.

Are DMT and LSD legal in Canada?

No. The Controlled Drugs and Substances Act (CDSA) lists both in Schedule III: LSD is item 5, and N,N-dimethyltryptamine (DMT) is item 7. The consolidation we read was current to 30 September 2026 (Justice Laws, CDSA). Except as authorised under the regulations, the Act prohibits possessing or producing a Schedule III substance, and it prohibits trafficking in one (sections 4, 5 and 7). Evidence: established.

Being in the same schedule does not mean the two are alike in effect or risk; it is a legal grouping. Penalties, exemptions and recent rule changes are covered in is DMT legal in Canada?. This is general information, not legal advice.

What we still don’t know

• How the two compare in the same people. The Basel trial is the first registered direct test; results were not published when we checked (unresolved).
• Why LSD lasts so much longer. Slow release from the receptor and DMT’s rapid breakdown are both discussed, but neither is proven to explain it in people (unresolved).
• What LSD’s extra receptor activity adds. Its adrenergic and dopamine binding comes from lab work (preliminary).
• How far reports carry over. DMT experience data come from small lab groups and self-selected online posts (preliminary).
• Effects in people the trials leave out, such as those with heart disease or psychiatric histories (unresolved).

The honest summary: DMT is not acid. The two share a main receptor and some visual effects, but differ in chemistry, history, receptor reach and, above all, time course. For the bigger picture, start with what is DMT.

Shroomverse sells mushroom products. This article is general information about DMT and LSD research and Canadian law. It is not medical, legal or purchasing advice, and it does not recommend any product.